Suppressing renal NADPH oxidase to treat diabetic nephropathy (Q36897331)

16 August 2017

1 reference

title

Suppressing renal NADPH oxidase to treat diabetic nephropathy (English)

1 reference

16 August 2017

Akihiro Tojo

1

1 reference

16 August 2017

Kensuke Asaba

series ordinal

2

1 reference

16 August 2017

Maristela L Onozato

series ordinal

3

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Expert Opinion on Therapeutic Targets

16 August 2017

1 reference

16 August 2017

11

1 reference

16 August 2017

8

1 reference

16 August 2017

1011-1018

1 reference

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

16 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Advanced glycation end products: sparking the development of diabetic vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

AGE, RAGE, and ROS in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Reactive oxygen species-regulated signaling pathways in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Effects of NADPH oxidase inhibitor in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Identification of renox, an NAD(P)H oxidase in kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Translocation of Glomerular p47phox and p67phox by Protein Kinase C-β Activation Is Required for Oxidative Stress in Diabetic Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Angiotensin II and oxidative stress in Dahl Salt-sensitive rat with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Salt Intake, Oxidative Stress, and Renal Expression of NADPH Oxidase and Superoxide Dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Antioxidative effect of p38 mitogen-activated protein kinase inhibitor in the kidney of hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Radical scavenging effect of gliclazide in diabetic rats fed with a high cholesterol diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

High glucose-suppressed endothelin-1 Ca2+ signaling via NADPH oxidase and diacylglycerol-sensitive protein kinase C isozymes in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Effect of combination therapy with dipyridamole and quinapril in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

High glucose-induced oxidative stress inhibits Na+/glucose cotransporter activity in renal proximal tubule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Angiotensin II blockade restores albumin reabsorption in the proximal tubules of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCepsilon-MAPK-p90RSK, and Rho-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

p38 MAPK and MAPK kinase 3/6 mRNA and activities are increased in early diabetic glomeruli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase-dependent superoxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Aspirin and PPAR-alpha activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Vitamin E and risk of type 2 diabetes in the women's health study randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Effect of NADPH oxidase inhibition on cardiopulmonary bypass-induced lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.8.1011

10.1517/14728222.11.8.1011

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference